RxDoctor Payments Data

Kirsten Kloepfer

Pediatric Allergy/Immunology · Indianapolis, INNPI 1730394206

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $70,091 of the $97,255 with a category attached, or 72.1%. Regeneron Healthcare Solutions, Inc. accounts for 88.1% of it on its own, with 10 other manufacturers making up the rest.

$97,255in general payments, 2019–2025

Across 164 payments — averaging $593.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$86K
  • Sanofi$4K
  • Biocryst Pharmaceuticals, Inc.$3K
  • Genentech USA, Inc.$2K
  • Novartis$1K
  • AstraZeneca$923
  • plus $370 from 5 others
$87,148in research payments, 2019–2025

Across 67 payments — averaging $1300.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Astrazeneca UK Limited$53K
  • Regeneron$34K

What the payments were for

  • Consulting fees$9,33910%
  • Speaking & faculty fees$70,09172%
  • Travel & lodging$14,74315%
  • Food & beverage$3,0103%
  • Education$720%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few pediatric allergy/immunology providers in Indianato place this figure against a meaningful peer group, so we don't.

Other pediatric allergy/immunology in Indianapolis

Where these figures come from

Is this you, or does something look wrong? →